Document is current
Any future updates will be listed below
-
Authors
Zhao, Tongtong
Chiang, Zachary D.
Morriss, Julia W.
LaFave, Lindsay M.
Murray, Evan M.
Del Priore, Isabella
Meli, Kevin https://orcid.org/0000-0002-9579-3829
Lareau, Caleb A. https://orcid.org/0000-0003-4179-4807
Nadaf, Naeem M.
Li, Jilong
Earl, Andrew S. https://orcid.org/0000-0002-5732-954X
Macosko, Evan Z. https://orcid.org/0000-0002-2794-5165
Jacks, Tyler https://orcid.org/0000-0001-5785-8911
Buenrostro, Jason D. https://orcid.org/0000-0001-9958-3987
Chen, Fei https://orcid.org/0000-0003-2308-3649
- License Information
-
More Information
Article History
Received: 1 February 2021
Accepted: 8 November 2021
First Online: 15 December 2021
Competing interests
: E.Z.M. and F.C. are listed as inventors on a patent application related to slide-seq. T.J. is a member of the board of directors of Amgen and Thermo Fisher Scientific. He is also a co-founder of Dragonfly Therapeutics and T2 Biosystems. T.J. serves on the scientific advisory board of Dragonfly Therapeutics, SQZ Biotech and Skyhawk Therapeutics, and is the president of Break Through Cancer. J.D.B. holds patents related to ATAC-seq and is on the scientific advisory board for Camp4, Seqwell and Celsee. F.C. is a paid consultant for Celsius Therapeutics and Atlas Bio. E.Z.M is a paid consultant for Atlas Bio. T.Z., E.Z.M., J.D.B. and F.C. have filed a patent application based on this work.
